Human Papilloma Virus (HPV) Vaccine
Overview
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Heparin (Na) and Heparin (Cl)'s dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 0.5 mL | 0.5 (0.5) | As recommended. | IM | Between 10 to 25 years for prevention of cervical cancer. |
| 0.5 mL | 0.5 (0.5) | As recommended. | IM | Usual Adult Dose for Human Papillomavirus Prophylaxis: Repeat dose in 2 months and 6 months for a total of 3 doses. (Between 9 to 26 years) |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Heparin (Na) and Heparin (Cl) is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Heparin (Na) and Heparin (Cl) is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Heparin (Na) and Heparin (Cl)
Back to top
Manufacturers of
Human Papilloma Virus (HPV) Vaccine
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic